Coagulation disorders and vascular diseases of the liver in patients with COVID-19.
Autor: | Tsafaridou M; Department of Gastroenterology and Hepatology, University Hospital of Heraklion, Crete, Greece., Maniadaki I; Department of Pediatrics, University Hospital of Heraklion, Crete, Greece., Koutroubakis I; Department of Gastroenterology and Hepatology, University Hospital of Heraklion, Crete, Greece., Samonakis DN; Department of Gastroenterology and Hepatology, University Hospital of Heraklion, Crete, Greece. |
---|---|
Jazyk: | angličtina |
Zdroj: | Clinical and experimental hepatology [Clin Exp Hepatol] 2022 Jun; Vol. 8 (2), pp. 97-102. Date of Electronic Publication: 2022 Jun 14. |
DOI: | 10.5114/ceh.2022.116972 |
Abstrakt: | The current coronavirus disease 2019 (COVID-19) pandemic has caused a global health emergency crisis, since its outbreak at the end of 2019. Although it mainly affects the respiratory system, it is documented that several important extrapulmonary manifestations exist in the context of the COVID-19 infection. Amongst the major pathophysiological mechanisms, the generation of a prothrombotic environment is increasingly recognized and is related to thromboembolic events. We conducted a review of the literature and summarized the coagulation disorders in the liver in patients with COVID-19. Competing Interests: The authors declare no conflict of interest. (Copyright © 2022 Clinical and Experimental Hepatology.) |
Databáze: | MEDLINE |
Externí odkaz: |